Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment.
Journal: JBMR plus
Published: August 28, 2025
Fibroblast Growth Factor 23 Trajectories in Children and Association with CKD Progression: The CKD in Children Study.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: August 20, 2025
FGF23 Trajectories in Children and Association with CKD Progression: The Chronic Kidney Disease in Children Study.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: August 20, 2025
Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults.
Journal: Journal of bone and mineral metabolism
Published: October 03, 2024
Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 12, 2024
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 12, 2024
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 12, 2024
Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: January 17, 2024
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
Journal: JBMR plus
Published: August 04, 2023
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 16, 2022
Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 05, 2022
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 25, 2022
Last Updated: 09/26/2026